Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

NCT05057702

Conditions
Ependymoma, Ependymoma Malignant, Ependymoma of Brain, +12 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
View Trial Details
Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT06057948

Conditions
High-risk Neuroblastoma, Metastatic Neuroblastoma, Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions
Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208

Conditions
Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

NCT06450041

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Comer Children's Hospital, University of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)

NCT07698899

Conditions
CNS Metastases, Central Nervous System Metastasis, Glioma, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions